Article
Analysis of the NLRP3 inflammasome components expression in triple-negative breast cancer patients with and without BRCA1 mutations.
Scientific reports - 21 Mar 2026
Faria Sara Socorro, Costantini Susan, Di Gennaro Elena, de Lima Vladmir C Cordeiro, Andrade Victor Piana, de Pádua Cristiano, Duval Vinícius, Marques Marcia Maria Chiquitelli, Magalhães Kelly Grace
Abstract excerpt
Triple-negative breast cancer (TNBC) is an aggressive and immunogenic breast cancer subtype frequently associated with BRCA1 alterations. Inflammation and innate immune sensing pathways, including inflammasomes, play complex and context-dependent roles in tumor progression and anti-tumor immunity. However, the prognostic significance of inflammasome components in TNBC remains poorly defined. We evaluated the...
Topics
Join the communities discussing this publication.
